These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25992338)

  • 41. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study.
    Olatosi OO; Sote EO; Orenuga OO
    Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of formocresol/ZOE sub-base pulpotomies utilizing alternative radiographic success criteria.
    Strange DM; Seale NS; Nunn ME; Strange M
    Pediatr Dent; 2001; 23(4):331-6. PubMed ID: 11572492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.
    Juneja P; Kulkarni S
    Eur Arch Paediatr Dent; 2017 Aug; 18(4):271-278. PubMed ID: 28780718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth.
    Aeinehchi M; Dadvand S; Fayazi S; Bayat-Movahed S
    Int Endod J; 2007 Apr; 40(4):261-7. PubMed ID: 17309744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An investigation of the relative efficacy of Buckley's Formocresol and calcium hydroxide in primary molar vital pulp therapy.
    Waterhouse PJ; Nunn JH; Whitworth JM
    Br Dent J; 2000 Jan; 188(1):32-6. PubMed ID: 10697342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formocresol and alternative primary molar pulpotomy medicaments: a review.
    Waterhouse PJ
    Endod Dent Traumatol; 1995 Aug; 11(4):157-62. PubMed ID: 7588337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long-term follow up.
    Fuks AB; Holan G; Davis JM; Eidelman E
    Pediatr Dent; 1997; 19(5):327-30. PubMed ID: 9260226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Premature exfoliation of primary molars related to the use of formocresol in a multivisit pulpotomy technique: a case report.
    Hunter ML
    Int J Paediatr Dent; 2003 Sep; 13(5):362-4. PubMed ID: 12924993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Pulpotomy Trial of Copaifera Langsdorffii Oil Resin Versus Formocresol and White Mineral Trioxide Aggregate in Primary Teeth.
    Musale PK; Soni AS
    Pediatr Dent; 2016; 38(2):5-12. PubMed ID: 27097854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of antimicrobial and cytotoxic effects of glutaraldehyde and formocresol.
    Hill SD; Berry CW; Seale NS; Kaga M
    Oral Surg Oral Med Oral Pathol; 1991 Jan; 71(1):89-95. PubMed ID: 1899722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical, radiographic, and histopathologic evaluation of Nd:YAG laser pulpotomy on human primary teeth.
    Odabaş ME; Bodur H; Bariş E; Demir C
    J Endod; 2007 Apr; 33(4):415-21. PubMed ID: 17368330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of a 2 percent buffered glutaraldehyde solution in pulpotomized primary teeth of schoolchildren.
    Fuks AB; Bimstein E; Guelmann M; Klein H
    ASDC J Dent Child; 1990; 57(5):371-5. PubMed ID: 2120303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative evaluation of pro-inflammatory cytokine levels in pulpotomized primary molars.
    Ozdemir Y; Kutukculer N; Topaloglu-Ak A; Kose T; Eronat C
    J Oral Sci; 2015 Jun; 57(2):145-50. PubMed ID: 26062864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary molar pulp therapy--histological evaluation of failure.
    Waterhouse PJ; Nunn JH; Whitworth JM; Soames JV
    Int J Paediatr Dent; 2000 Dec; 10(4):313-21. PubMed ID: 11310245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence-based assessment: evaluation of the formocresol versus ferric sulfate primary molar pulpotomy.
    Loh A; O'Hoy P; Tran X; Charles R; Hughes A; Kubo K; Messer LB
    Pediatr Dent; 2004; 26(5):401-9. PubMed ID: 15460294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternative method of hemorrhage control in full strength formocresol pulpotomy.
    Thompson KS; Seale NS; Nunn ME; Huff G
    Pediatr Dent; 2001; 23(3):217-22. PubMed ID: 11447951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the novel anti-inflammatory agent tetrandrine as a pulpotomy medicament in a canine model.
    Seow WK; Thong YH
    Pediatr Dent; 1993; 15(4):260-6. PubMed ID: 8247901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A study concerning radiographic diagnosis in dental caries of primary teeth. 1. The investigation on the indications for pulpotomy with formocresol].
    Ono M; Maeda T; Tani H; Kurihara Y
    Shoni Shikagaku Zasshi; 1991; 29(1):154-8. PubMed ID: 1784858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized study of sodium hypochlorite versus formocresol pulpotomy in primary molar teeth.
    Ruby JD; Cox CF; Mitchell SC; Makhija S; Chompu-Inwai P; Jackson J
    Int J Paediatr Dent; 2013 Mar; 23(2):145-52. PubMed ID: 22502601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.